Pfizer Animal Health and The Hippolia Foundation have announced the formation of a strategic partnership to advance equine health through research and educational programs.

The Hippolia Foundation—a network of leading French equine institutions together with international partners—will collaborate with Pfizer to accelerate advancement in innovation on the diagnosis, treatment and prevention of equine disease. The Hippolia partner organizations and Pfizer are initially investing more than $5 million over three years.

"This is an excellent example of a public/private initiative to advance our scientific knowledge and improve animal health and welfare," said Pierre Lekeux, president of The Hippolia Foundation.

The two principal areas of collaboration to be developed between Pfizer and The Hippolia Foundation will focus on respiratory disorders and on infectious diseases